bosutinib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group
Sitenames

Any (1)

Phase 1/2 (1)

Interventional (1)

Children's Oncology Group (1)

No (1)

No (1)

Adult (18+) (1)
Pediatric (Under 18) (1)

center (1)
children (1)
kapiolani (1)
medic (1)
women (1)

I am/have/had

I am/have/hadchronic myeloid leukemia

I am/have/hadleukemia

I am/have/hadchronic phase chronic myeloid leukemia

I am/have/hadabsolute neutrophil count

I am/have/hadphiladelphia chromosome

I am/have/hadblastic phase chronic myeloid leukemia

I am/have/hadtyrosine

I am/have/hadrenal function

I am/have/hadschwartz

I am/have/hadcml - philadelphia chromosome

I am/have/hadstem cell transplantation

I am/have/hadkarnofsky performance status

I am/have/hadchromosome banding

I am/have/hadplatelet transfusions

I am/have/hadejection fraction

I am/have/hadgilbert's syndrome

I am/have/hadimmunodeficiencies

I am/have/hadt315i mutation

I am/have/hadhair thinning

I am/have/hadimmunodeficiency

added new label for I am/have/had

more

I am looking for

I am looking forbosutinib

I am looking fortyrosine kinase inhibitor

I am looking fortyrosine

I am looking foranagrelide

I am looking forpediatric

I am looking forbiologic agent

I am looking forhydroxyurea

I am looking forgrowth factor

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For pediatric ages
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia"

This is a Phase 1-2, multicenter, international, single-arm, open-label study designed to identify a recommended dose of bosutinib administered orally once daily in pediatric patients with newly diagnosed chronic phase Ph+ CML (ND CML) and pediatric patients with Ph+CML who have received at least one prior TKI therapy (R/I CML), …

gilbert's syndrome

pediatric

chronic myeloid leukemia

platelet transfusion

schwartz

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.